Changing trends in the risk factors for second primary malignancies after autologous stem cell transplantation for multiple myeloma before and after the introduction of proteasome inhibitors and immunomodulatory drugs

The incidence of second primary malignancies (SPM) in long-term survivors of multiple myeloma (MM) is increasing because of increased life expectancy. We retrospectively analyzed the risk factors for SPM in patients with MM after autologous stem cell transplantation (ASCT) before and after the intro...

Descripción completa

Detalles Bibliográficos
Autores principales: Takamatsu, Hiroyuki, Matsuda, Tomohiro, Mizuno, Shohei, Takahashi, Tsutomu, Fuchida, Shin-ichi, Hanamura, Ichiro, Kataoka, Keisuke, Tsukada, Nobuhiro, Matsumoto, Morio, Hangaishi, Akira, Doki, Noriko, Uchida, Naoyuki, Sawa, Masashi, Maruyama, Yumiko, Kurahashi, Shingo, Nagafuji, Koji, Harazaki, Yoriko, Kako, Shinichi, Iida, Shinsuke, Ichinohe, Tatsuo, Kanda, Yoshinobu, Atsuta, Yoshiko, Sunami, Kazutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2023
Materias:
Article - Plasma Cell Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690906/
https://www.ncbi.nlm.nih.gov/pubmed/37470160
http://dx.doi.org/10.3324/haematol.2023.283202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690906/
https://www.ncbi.nlm.nih.gov/pubmed/37470160
http://dx.doi.org/10.3324/haematol.2023.283202

Ejemplares similares